Narcolepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with type 1 narcolepsy (a sleep disorder that causes sudden muscle weakness and excessive sleepiness).
- You are either not yet being treated for narcolepsy (for the newly diagnosed group) or are already being monitored for narcolepsy over time (for the follow-up group).
- You speak and understand French.
- You have given your free and informed consent to participate (or, if you are a child, your parent or legal guardian has given consent on your behalf).
- You are covered by a health insurance plan.
For healthy volunteers (control participants):
- You have not been diagnosed with a sleep disorder that causes excessive daytime sleepiness, and your score on a standard sleepiness questionnaire is 10 or below out of 24.
Who may not be able to join:
- You have had an infection requiring antibiotic treatment in the past 3 months.
- You have a condition that affects your immune system.
- You have received treatment that affects the immune system, or chemotherapy, within the past 60 days, or such treatment is planned during the study period.
- You have a long-term digestive condition, or you have had weight-loss (bariatric) surgery in the past year.
- You are currently taking laxatives.
- You currently live in a medical or care institution.
- You are under legal protection, guardianship, or supervised care (confirm with trial site).
- You (or your legal representative, if you are a minor) are unable to give consent.
- You start taking antibiotics, laxatives, or any other medication that could significantly affect gut bacteria during the enrolment period.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Catherine Dunyach-Remy, CHU de Nimes
Phone: 0466683202
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Plasma bacterial translocation profiles between groups
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.